By using this website, you agree to the storing of cookies on your device. These cookies are used to collect information about how you interact with our website and allow us to remember you. We use this information in order to improve and customize your browsing experience and for analytics and metrics about our visitors both on this website and other media. To find out more about the cookies we use, see our Cookie Policy.

Slingshot_logo-web-white

Replacing Biologically-Derived Reagents with Synthetic Cells

The World’s First Customizable, On-Demand Synthetic Cells

Synthetic cells are poised to change the face of healthcare—improving global access to diagnostic technologies, increasing the accuracy and precision of assays, and introducing quantitative capabilities for legacy instruments.

  • Level-up from solid-core beads
  • Customizable to any cell population–even rare diseases
  • Consistency that reduces your costs
  • Rapid, on-demand manufacturing that saves you time
  • Cold-chain shipping and storage are things of the past

Download the guide to learn more about TruCytes and other synthetic 5 cell solutions.

FEATURED SECTORS

Biopharma

Life Sciences

Cell Therapies

Diagnostics

AstraZeneca
Genentech
Amgen
Kite
Instil Bio
Sana Biotechnology
bluebird bio
Beckman Coulter
BD Biosciences
Cytek
Bio-Rad
Sysmex
Abbott
Covance

SLINGSHOT’S TECHNOLOGY

The Most Advanced and Ideal Cell Control

The Slingshot platform is the world’s first on demand, synthetic cell design platform to address the industry’s reliance on and limitations around biologically-derived cellular controls.